eXoZymes (EXOZ US)

Analysis

Health Care • United States

eXoZymes Inc. operates as a biotechnology company. The Company develops a biomanufacturing platform that offers the tools and insight to control and optimize nature's own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. eXoZymes serves customers in the United States.

Refresh

Exchange Announcement • 10 Oct 2026 00:10

Current Report (Form 8-K | Period ending 2026-10-09)

Exchange Announcement • 19 Sep 2026 01:24

Current Report (Form 8-K | Period ending 2026-09-17)

Exchange Announcement • 14 Aug 2026 03:50

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 02 Jul 2026 04:30

Current Report (Form 8-K | Period ending 2026-06-30)

Exchange Announcement • 01 Jul 2026 04:15

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Current Report (Form 8-K | Period ending 2026-10-09)

Current Report (Form 8-K | Period ending 2026-09-17)

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Current Report (Form 8-K | Period ending 2026-06-30)

424B5 | Prospectus